Active surveillance for early-stage pros
β
Marc A. Dall'Era; Matthew R. Cooperberg; June M. Chan; Benjamin J. Davies; Peter
π
Article
π
2008
π
John Wiley and Sons
π
English
β 114 KB
## Abstract The natural history of prostate cancer is remarkably heterogeneous and, at this time, not completely understood. The widespread adoption and application of prostateβspecific antigen (PSA) screening has led to a dramatic shift toward the diagnosis of lowβvolume, nonpalpable, earlyβstage